Emily Minkow
Corporate Officer/Principal at PREVAIL THERAPEUTICS INC.
Profile
Emily Minkow is currently the Director at Stylus Medicine, Inc. and a Venture Partner at RA Capital Management LP (Private Equity).
She was previously the Chief Business Officer at Prevail Therapeutics, Inc. and the Executive Director-Business Development at Celgene Corp.
Ms. Minkow received her undergraduate degree from Princeton University and her MBA from Harvard Business School.
Emily Minkow active positions
Companies | Position | Start |
---|---|---|
PREVAIL THERAPEUTICS INC. | Corporate Officer/Principal | 2018-10-31 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Private Equity Investor | 2021-12-31 |
Stylus Medicine, Inc.
Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures. | Director/Board Member | - |
Former positions of Emily Minkow
Companies | Position | End |
---|---|---|
CELGENE | Corporate Officer/Principal | 2017-09-30 |
Training of Emily Minkow
Harvard Business School | Masters Business Admin |
Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
Stylus Medicine, Inc.
Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures. | Health Technology |
- Stock Market
- Insiders
- Emily Minkow